vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and BGSF, INC. (BGSF). Click either name above to swap in a different company.
BGSF, INC. is the larger business by last-quarter revenue ($22.0M vs $20.0M, roughly 1.1× AGIOS PHARMACEUTICALS, INC.). BGSF, INC. runs the higher net margin — -5.3% vs -541.1%, a 535.8% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs -9.4%). BGSF, INC. produced more free cash flow last quarter ($1.7M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs -5.3%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.
AGIO vs BGSF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $22.0M |
| Net Profit | $-108.0M | $-1.2M |
| Gross Margin | 90.6% | 35.0% |
| Operating Margin | -608.9% | -17.6% |
| Net Margin | -541.1% | -5.3% |
| Revenue YoY | 86.1% | -9.4% |
| Net Profit YoY | -11.9% | -18.2% |
| EPS (diluted) | $-1.86 | $-0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $22.0M | ||
| Q3 25 | $12.9M | $26.9M | ||
| Q2 25 | $12.5M | $23.5M | ||
| Q1 25 | $8.7M | $20.9M | ||
| Q4 24 | $10.7M | $24.3M | ||
| Q3 24 | $9.0M | $29.8M | ||
| Q2 24 | $8.6M | $25.7M | ||
| Q1 24 | $8.2M | $24.5M |
| Q4 25 | $-108.0M | $-1.2M | ||
| Q3 25 | $-103.4M | $-5.8M | ||
| Q2 25 | $-112.0M | $-3.7M | ||
| Q1 25 | $-89.3M | $-722.0K | ||
| Q4 24 | $-96.5M | $-981.0K | ||
| Q3 24 | $947.9M | $-804.0K | ||
| Q2 24 | $-96.1M | $-761.0K | ||
| Q1 24 | $-81.5M | $-792.0K |
| Q4 25 | 90.6% | 35.0% | ||
| Q3 25 | 87.0% | 35.9% | ||
| Q2 25 | 86.3% | 35.8% | ||
| Q1 25 | 87.6% | 36.2% | ||
| Q4 24 | 88.3% | 35.9% | ||
| Q3 24 | 91.3% | 35.9% | ||
| Q2 24 | 82.6% | 37.3% | ||
| Q1 24 | 92.3% | 38.1% |
| Q4 25 | -608.9% | -17.6% | ||
| Q3 25 | -907.4% | -3.5% | ||
| Q2 25 | -1020.1% | -18.8% | ||
| Q1 25 | -1222.0% | 1.6% | ||
| Q4 24 | -1165.3% | -15.7% | ||
| Q3 24 | -1146.9% | -3.4% | ||
| Q2 24 | -1228.3% | -5.7% | ||
| Q1 24 | -1124.3% | 1.7% |
| Q4 25 | -541.1% | -5.3% | ||
| Q3 25 | -803.1% | -21.6% | ||
| Q2 25 | -899.4% | -15.9% | ||
| Q1 25 | -1023.3% | -3.5% | ||
| Q4 24 | -899.6% | -4.0% | ||
| Q3 24 | 10574.7% | -2.7% | ||
| Q2 24 | -1115.7% | -3.0% | ||
| Q1 24 | -995.8% | -3.2% |
| Q4 25 | $-1.86 | $-0.12 | ||
| Q3 25 | $-1.78 | $-0.52 | ||
| Q2 25 | $-1.93 | $-0.34 | ||
| Q1 25 | $-1.55 | $-0.06 | ||
| Q4 24 | $-1.44 | — | ||
| Q3 24 | $16.22 | $-0.07 | ||
| Q2 24 | $-1.69 | $-0.07 | ||
| Q1 24 | $-1.45 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $48.1M |
| Total Assets | $1.3B | $57.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | — | ||
| Q3 25 | $92.7M | $41.2M | ||
| Q2 25 | $80.9M | $2.8M | ||
| Q1 25 | $79.0M | $2.0M | ||
| Q4 24 | $76.2M | $32.0K | ||
| Q3 24 | $253.7M | $262 | ||
| Q2 24 | $84.5M | $226 | ||
| Q1 24 | $118.8M | $50 |
| Q4 25 | $1.2B | $48.1M | ||
| Q3 25 | $1.3B | $50.7M | ||
| Q2 25 | $1.4B | $78.3M | ||
| Q1 25 | $1.5B | $81.8M | ||
| Q4 24 | $1.5B | $82.3M | ||
| Q3 24 | $1.6B | $82.9M | ||
| Q2 24 | $660.5M | $83.2M | ||
| Q1 24 | $743.9M | $83.6M |
| Q4 25 | $1.3B | $57.8M | ||
| Q3 25 | $1.4B | $83.6M | ||
| Q2 25 | $1.5B | $149.7M | ||
| Q1 25 | $1.6B | $152.3M | ||
| Q4 24 | $1.7B | $150.1M | ||
| Q3 24 | $1.8B | $157.3K | ||
| Q2 24 | $773.1M | $159.8K | ||
| Q1 24 | $849.7M | $170.6K |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $1.7M |
| Free Cash FlowOCF − Capex | $-97.3M | $1.7M |
| FCF MarginFCF / Revenue | -487.5% | 7.6% |
| Capex IntensityCapex / Revenue | 5.6% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $-16.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $1.7M | ||
| Q3 25 | $-88.2M | $-4.8M | ||
| Q2 25 | $-77.1M | $2.2M | ||
| Q1 25 | $-111.5M | $1.1M | ||
| Q4 24 | $-133.2M | $3.2M | ||
| Q3 24 | $-84.2M | $6.5M | ||
| Q2 24 | $-72.6M | $7.3M | ||
| Q1 24 | $-99.9M | $7.4M |
| Q4 25 | $-97.3M | $1.7M | ||
| Q3 25 | $-89.7M | $-4.9M | ||
| Q2 25 | $-78.0M | $2.1M | ||
| Q1 25 | $-112.3M | $1.0M | ||
| Q4 24 | $-134.1M | $2.5M | ||
| Q3 24 | $-84.6M | $6.5M | ||
| Q2 24 | $-72.7M | $7.3M | ||
| Q1 24 | $-100.0M | $6.9M |
| Q4 25 | -487.5% | 7.6% | ||
| Q3 25 | -696.5% | -18.1% | ||
| Q2 25 | -626.2% | 9.1% | ||
| Q1 25 | -1286.4% | 5.0% | ||
| Q4 24 | -1250.1% | 10.2% | ||
| Q3 24 | -944.2% | 21.7% | ||
| Q2 24 | -844.4% | 28.5% | ||
| Q1 24 | -1221.2% | 28.1% |
| Q4 25 | 5.6% | 0.1% | ||
| Q3 25 | 12.1% | 0.4% | ||
| Q2 25 | 7.0% | 0.0% | ||
| Q1 25 | 8.8% | 0.1% | ||
| Q4 24 | 9.0% | 3.0% | ||
| Q3 24 | 4.7% | 0.0% | ||
| Q2 24 | 1.8% | 0.0% | ||
| Q1 24 | 1.7% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGIO
Segment breakdown not available.
BGSF
| Contract Field Talent | $21.4M | 97% |
| Other | $595.0K | 3% |
